SYNAPSE SYMPHONY INC.

PITTSBURGH, PA, 15213

Unclaimed

Subcontracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

Role	Agency	Description	Vehicle	Obligated	Action date	Period
Subcontractor	Department of Defense	IN THE EMBEDDED ENTREPRENEURSHIP INITIATIVE (EEI) PROGRAM, OUR FIRM WILL PLAY A CRUCIAL AND MULTIFACETED ROLE IN TRANSFORMING SHARPFOCUS TECHNOLOGY INTO A VIABLE COMMERCIAL PRODUCT. FOR THIS WE WILL FORM A SYNERGISTIC PARTNERSHIP WITH CMU AND FOSTER A COLLABORATIVE NETWORK THAT ACCELERATES THE DEVELOPMENT AND DEPLOYMENT OF SHARPFOCUS TECHNOLOGY. ONCE THE EE AND FDA CONSULTANT WILL BE HIRED, A STRATEGIC PLANNING WILL BE MADE, AND WE WILL TAKE LEAD ON FILING NEW IPS RELATED TO THE TECHNOLOGY AND LICENSING THE EXISTING IP RIGHTS FROM CMU. ALONG WITH CMU, WE WILL LEAD THE PROCESS OF IDENTIFICATION AND PENETRATION OF THE NICHE MARKETS, CREATE STRATEGIES FOR SCALING SHARPFOCUS TO BROADER MARKETS, AND ENGAGE DIRECTLY WITH END-USERS AND CUSTOMERS TO REFINE OUR TECHNOLOGY BASED ON REAL-WORLD FEEDBACK. THIS CUSTOMER-CENTRIC APPROACH WILL ENSURE THAT OUR APPROACH MEETS ACTUAL MARKET NEEDS AND DEMANDS. WE WILL REPRESENT OUR TECHNOLOGY AT DIFFERENT PLATFORMS LIKE CONFERENCES, ASSOCIATION WORKSHOPS ETC. TO ENSURE PROPER REIMBURSEMENT AND COVERAGE FOR OUR NEW DEVICE/PROCEDURE, WE WILL UNDERTAKE A MULTI-PRONGED APPROACH. FIRST, WE WILL COLLABORATE WITH MEDICAL SPECIALISTS AND RELEVANT SOCIETIES TO ESTABLISH A CATEGORY III CPT CODE, WHICH IS A CRUCIAL STEP IN THE REIMBURSEMENT PROCESS. SIMULTANEOUSLY, WE WILL COMPILE REAL- WORLD EVIDENCE FROM CLINICAL STUDIES, DEMONSTRATING THE DEVICE'S EFFICACY, SAFETY, AND COST- EFFECTIVENESS COMPARED TO EXISTING PAIN TREATMENTS. THIS EVIDENCE WILL BE A VITAL COMPONENT IN OUR VALUE PROPOSITION TO PAYERS. ARMED WITH THIS COMPELLING EVIDENCE, WE WILL PROACTIVELY ENGAGE WITH COMMERCIAL PAYERS AND MEDICARE CONTRACTORS. OUR GOAL WILL BE TO PRESENT A PERSUASIVE CASE FOR COVERING THE NEW DEVICE, HIGHLIGHTING ITS VALUE PROPOSITION AND THE POTENTIAL BENEFITS IT OFFERS TO PATIENTS AND THE HEALTHCARE SYSTEM AS A WHOLE. FURTHER WITH THE GUIDANCE OF FDA CONSULTANT REGULATORY PATHWAYS WILL BE EXPLORED AND AN INITIATIVE WILL BE TAKEN TO START THE PROCEDURE BY SCHEDULING THE MEETING WITH PROGRAM MANAGER. FURTHER AS WORKLOAD WILL INCREASE SO TEAM EXPANSION STRATEGIES WILL BE PLANNED BY EXPLORING OTHER FUNDING OPPORTUNITIES AS SEED GRANTS, EARLY INVESTORS ETC. AFTER COMPLETION OF EEI PROGRAM, CMU WILL COMPILE ALL OBSERVATION AND MILESTONES PROGRESS AND PREPARE A REPORT FOR SUBMISSION TO PROGRAM MANAGER. 1990993-501857 Parent award context Parent award agency: Department of Defense · Defense Advanced Research Projects Agency Parent award NAICS: 541715 Parent award performance state: VA Parent award description: EMBEDDED ENTREPRENEURSHIP INITIATIVE (EEI) View parent award on USAspending	—	$234,889	May 27, 2025	— – —

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.